I

Inhalerx Ltd
ASX:IRX

Watchlist Manager
Inhalerx Ltd
ASX:IRX
Watchlist
Price: 0.025 AUD Market Closed
Market Cap: AU$5.3m

Operating Margin

-166.3%
Current
Improving
by 647.5%
vs 3-y average of -813.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-166.3%
=
Operating Income
AU$-1.4m
/
Revenue
AU$837.6k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-166.3%
=
Operating Income
AU$-1.4m
/
Revenue
AU$837.6k

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Inhalerx Ltd
ASX:IRX
5.4m AUD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
36.5B USD
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
18.9B AUD
Loading...
JP
M3 Inc
TSE:2413
1.4T JPY
Loading...
US
Doximity Inc
NYSE:DOCS
7.6B USD
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
5.2B USD
Loading...
SE
Sectra AB
STO:SECT B
43.2B SEK
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
26.7B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
283.3B INR
Loading...
US
Heartflow Inc
NASDAQ:HTFL
2.8B USD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
39th
Based on 3 951 companies
39th percentile
-166.3%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Inhalerx Ltd
Glance View

Market Cap
5.3m AUD
Industry
Health Care

InhaleRx Ltd. engages in the development and commercialization of medical technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-01-11. The firm is focused on developing inhaled therapies and medicine delivery systems. The company offers Medihale, an inhaler device with sealed pod designed for use of medical cannabis inhaled formulations. The company utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper proof Medihale Pods provide patients with the additional Medical Cannabis c-liquid security. Its Medihale Starter Kit Pro comes with inhaler battery controller with universal serial bus (USB) charging cable, protective charging case and protective charging case USB charging cable.

IRX Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-166.3%
=
Operating Income
AU$-1.4m
/
Revenue
AU$837.6k
What is Inhalerx Ltd's current Operating Margin?

The current Operating Margin for Inhalerx Ltd is -166.3%, which is above its 3-year median of -813.7%.

How has Operating Margin changed over time?

Over the last 3 years, Inhalerx Ltd’s Operating Margin has increased from -819.9% to -166.3%. During this period, it reached a low of -3 713.1% on Dec 31, 2022 and a high of -78.1% on Jun 30, 2024.

Back to Top